New Jersey Chapter of AACE 10th Annual Meeting & Symposium

September 16, 2017

The New Jersey Chapter of AACE program committee has worked very hard to provide a relevant activity for the practicing clinical physician and other healthcare providers seeking education with an emphasis in endocrine disease.

This program has been planned to provide pertinent scientific and clinical information to help you achieve the best solutions in the diagnosis and therapeutic management of patients presenting with endocrine disease. Attendees will obtain updates in not only common and uncommon endocrine disorders, but also newer treatment modalities.

Providing exceptional patient care requires continuing high quality education. The American Association of Clinical Endocrinologists (AACE) was founded in 1991 by a visionary group of leaders to serve as the active voice for clinical endocrinologists. The impetus behind AACE's efforts has always been quality and cost-effective patient care for those with endocrine diseases and disorders. We hope that you will find this program of great value to you in your practice.

Target Audience

Endocrinologists, MDs & DOs, advanced practice clinicians and other healthcare professionals interested in the treatment of endocrine disease living or working in New Jersey.

Learning Objectives

  1. After participating in a pre-meeting assessment tool, attendees will be able to recognize areas of potential shortcoming and strive to improve knowledge and consequential healthcare practices.
  2. Identify the FDA-approved therapies for RAI-refractory thyroid cancer
  3. Discuss the role of the MAPK signaling pathway in thyroid cancer biology
  4. Understand the targeted therapies being investigated in clinical trials
  5. Review the process for diagnosing Cushing’s, including tests used to distinguish true Cushing’s from pseudo-Cushing’s
  6. Understand testing needed to localize Cushing’s
  7. Discuss challenges and strategies for correctly distinguishing between pituitary, adrenal, and ectopic Cushing’s
  8. To understand the new Quality Payment Program
  9. To learn the importance of specialty-specific quality registries
  10. To enhance understanding of continuous quality improvement and self-approvement
  11. Recognize the complications of hypoparathyroidism
  12. Review conventional therapy of hypoparathyroidism with calcium and active vitamin D
  13. Identify patients that may benefit from treatment with PTH(1-84) therapy
  14. Define Pediatric Obesity based on BMI Percentiles
  15. Identify Medical Treatment Options
  16. Identify Indications for Surgical Treatment.
  17. The participant will be able to understand the pathophysiologic mechanisms surrounding functional hypothalamic amenorrhea, including how exercise, diet, and stress, among other factors, play a role
  18. The participants will be able to describe the transient recovery state that exists upon treatment of functional hypothalamic amenorrhea where folliculogenesis may be occurring prior to return of menses
  19. The participants will understand that this transition state may mimic a polycystic ovarian syndrome state but that the treatment approach is different due to the underlying pathology
  20. At the conclusion of the meeting, attendees will be able to measure learning that occurred that will enable the use of new healthcare techniques and practices and to review or confirm existing care modalities.
  21. What is the Quality Payment Program?
  22. What is the Merit-based Incentive Payment Systems (MIPS)
  23. What do you need to do in your practice?
Additional information
Available for MOC Points?: 
Practice Area: 
General Endo
Course summary
Available credit: 
  • 8.00 AMA
  • 8.00 Attendance
Course opens: 
Course expires: 
Event starts: 
09/16/2017 - 8:00am
Event ends: 
09/16/2017 - 7:00pm

Saturday, September 16, 2017

8:00 - 8:45 AMRegistration and Continental Breakfast
8:45 - 9:00 AM
Welcoming Remarks & Pre Meeting Assessment
9:00 - 10:00 AMThyroid Cancer Therapeutics
Alan Ho, MD, PhD
10:00 - 11:00 AMChallenges in Diagnosing and Localizing Cushing’s Syndrome
Eliza B. Geer, MD
11:00 - 11:30 AMBreak
11:30 - 12:30 PMStriving for Quality in the Era of Pay-for-Performance:
Lessons learned from CESQIP
12:30 - 12:45 PMNJ AACE Business Meeting
12:45 - 1:45 PMLunch
1:45 - 2:45 PMHypoparathyroidism: Complications and treatment
Natalie Cusano, MD, MS
2:45 - 3:15 PMBreak
3:15 - 4:15 PMUpdate on Pediatric Obesity Treatment
Bassil Kubaoui, MD, PhD, FAAP
4:15 - 5:15 PMFactors Influencing Functional Hypothalamic Amenorrhea and the Transient State Induced with Treatment
Richard Scott, MD, HCLD
5:15 - 5:30 PMPost Meeting Assessment
5:30 - 7:00 PMBilling & Coding Session / Dinner from Mehndi
5:30 - 5:45 PMAACE and QPP - Where are we going?
5:45 - 7:00 PMPanel Discussion
Reinhard Beel, CPC, AACE-CEC
Support Material
7:00 PMAdjourn
Morristown, NJ
United States

Reinhard W. Beel, CPC, AACE-CEC
Endocrine Business Consultant
Carlisle, PA

Natalie E. Cusano, MD, MS
Assistant Professor of Medicine
Columbia University Medical Center
New York, NY

Eliza B. Geer, MD 
Medical Director, Multidisciplinary Pituitary and Skull Base Tumor Center
Associate Professor of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

Alan Ho, MD, PhD
Assistant Member of Medicine
Memorial Sloan Kettering Cancer Center
New York, NY

William Inabnet, III, MD, FACS
Chairman, Department of Surgery
Mount Sinai Beth Israel Medical Center
Eugene W. Friedman Professor of Surgery
Icahn School of Medicine at Mount Sinai
New York, NY

Bassil Kublaoui, MD-PhD, FAAP
Associate Professor of Clinical Pediatrics
Program Director
Pediatric Endocrinology Fellowship Program
Children’s Hospital of Philadelphia
Perelman School of Medicine at the
University of Pennsylvania
Philadelphia, PA

Jamie Morris, MD, FACOG
Clinical Assistant Professor, Division of Reproductive Endocrinology
Department of Obstetrics, Gynecology, and Reproductive Sciences
Rutgers-Robert Wood Johnson Medical School
Morristown, NJ

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the American Association of Clinical Endocrinologists (AACE) and the New Jersey Chapter of AACE. The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of 8.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Available Credit

  • 8.00 AMA
  • 8.00 Attendance

Accreditation Period

Course opens: 
Course expires: 


Please login or register to take this course.